Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

BUY
$1.48 - $2.19 $25,717 - $38,055
17,377 New
17,377 $27,000
Q2 2022

Aug 09, 2022

BUY
$1.59 - $2.7 $72,273 - $122,728
45,455 New
45,455 $76,000
Q4 2019

Feb 04, 2020

SELL
$2.83 - $4.61 $51,378 - $83,694
-18,155 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$3.83 - $4.72 $69,533 - $85,691
18,155 New
18,155 $71,000
Q4 2017

Feb 09, 2018

SELL
$3.88 - $6.96 $245,173 - $439,795
-63,189 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$2.91 - $4.71 $183,879 - $297,620
63,189
63,189 $0

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $510M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.